Estimation of tumour hypoxic fraction from clinical data sets compatible with accelerated repopulation

Acta Oncologica

Volumn 37, Issue 3, 1998, Pages 263-268

  Jones, Bleddyn ^a   Dale, Roger G ^b  

^a CLATTERBRIDGE CENTRE FOR ONCOLOGY   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CELL POPULATION; DATA ANALYSIS; FRACTIONATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERBARIC OXYGEN; OXYGENATION; PRIORITY JOURNAL; RECTUM CANCER; REOXYGENATION;

CELL HYPOXIA; HUMANS; NEOPLASMS; OXYGEN; TIME FACTORS;

EID: 0031750356     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418698429568     Document Type: Article

References (36)

1. Denekamp J. Changes in the rate of repopulation during multifraction irradiation of mouse skin. Br J Radiol 1973; 46: 381-7.
2. Denekamp J, Stewart FA, Douglas BG. Changes in the proliferation rate of mouse epidermis after irradiation: continuous labelling studies. Cell Tissue Kinet 1973; 9: 19-29.
3. Withers HR, Taylor JMG, Maciejewski B. The hazard of accelerated tumour clonogen repopulation during radiotherapy. Acta Oncol 1988; 27: 131-46.
4. Maciejewski B, Majewski S. Dose fractionation and tumour repopulation in radiotherapy for bladder cancer. Radiother Oncol 1991; 21: 163-70.
5. Bentzen SM, Thames HD. Clinical evidence for tumour clonogen regeneration: interpretations of the data. Radiother Oncol 1991; 22: 161-6.
6. Jones B, Dale RG. Cell loss factors and the linear quadratic model. Radiother Oncol 1995; 37: 136-9.
7. Trott KR, Kummermehr J. Rapid repopulation in radiotherapy:a debate on mechanism. Accelerated repopulation in tumours and normal tissues. Radiother Oncol 1991; 22: 159-60.
8. Fowler JF. Rapid repopulation in radiotherapy: a debate on mechanism. The phantom of tumour treatment - continually rapid proliferation unmasked. Radiother Oncol 1991; 22: 156-8.
9. Jones B. Rapid repopulation in radiotherapy: a debate on mechanism (letter). Radiother Oncol 1992; 24: 124-5.
10. pot is not. Int J Radiat Oncol Biol Phys 1996; 35: 633-4.
11. Tannock I. The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumour. Br J Cancer 1968; 22: 258-73.
12. Hirst DG, Denekamp J. Tumour cell proliferation in relation to the vasculature. Cell Tissue Kinet 1979; 12: 31-42.
13. Jones B. Campeljohn RS. Stathmokinetic measurement of tumour cell proliferation in relation to vascular proximity. Cell Tissue Kinet 1983; 16: 351-5.
14. Denekamp J. Inadequate vasculature in solid tumours: consequences for cancer research strategies. In: Radiation science - of molecules, mice and men. Br J Radiol 1992, (Supplement 24): 111-117.
15. Kinzler KW, Vogelstein A. Life (and death) in a malignant tumour. Nature 1996; 379: 19-20.
16. Denekamp J. Cell kinetics and cancer therapy. Springfield, IL, USA: Charles C Thomas, 1982: 112-6.
17. Gray LH, Conger AD, Ebert M, Hornsey S, Scott OCA. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol 1953; 26: 638-48.
18. Stone HB, Brown JM, Phillips TL, Sutherland RM. Oxygen in human tumours: correlation between methods of measurement and response to therapy. Radiat Res 1993; 136: 422-34.
19. Nordsmark M, Overgaard M, Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 1996; 41: 31-40.
20. Hoeckel M, Schlenger K, Milze M, et al. Hypoxia and radiation response in human tumours. Semin Radiat Oncol 1996; 6: 3-9.
21. Denekamp J, Fowler JF. ARCON - current status: summary of a workshop on preclinical and clinical studies. Acta Oncol 1997; 36: 517-26.
22. Barendsen GW. Dose fractionation, dose rale and iso-effect relationships for normal tissue responses. Int J Radiat Oncol Biol Phys 1982; 8: 1981-97.
23. Dale RG. The application of the linear quadratic theory to fractionated and protracted radiotherapy. Br J Radiol 1985; 58: 515-28.
24. Alper T. Cellular radiobiology. Cambridge: Cambridge University Press, 1979.
25. Revesz L, Palcic B. Radiation dose dependence of the sensitisation of oxygen and oxygen mimic sensitisers. Acta Radiol Oncol 1985; 24: 209-17.
26. Marples B, Joiner MC, Skov KA. The effect of oxygen on low dose hypersensitivity and radioresistance in Chinese hamster V79-379A cells. Radiat Res 1994; 138: S17-20.
27. Horsman MR. Hypoxia in tumours: its relevance, identification and modification. In: Beck-Bornhol H-P, ed. Current topics in clinical radiobiology of tumours. Berlin: Springer Verlag, 1993.
28. Hodgkiss RJ, Wardman P. The measurement of hypoxia in tumours. In: Radiation science - of molecules, mice and men. Br J Radiol 1992, (Supplement 24): 105-110.
29. Howes AE. An estimation of changes in the proportion and absolute numbers of hypoxic cells after irradiation of transplanted C3H mouse tumours. Br J Radiol 1969; 42: 441-7.
30. Scott OCA. Mathematical model of repopulation and reoxygenation in radiotherapy. Br J Radiol 1990; 63: 821-3.
31. Denekamp J, McNally NJ, Fowler JF, Joiner MC. Misonidazole in fractionated radiotherapy: are many small fractions best? Br J Radiol 1980; 53: 981-90.
32. Amdur R, Parsons J, Fitzgerald L, et al. The effect of overall treatment time on local control in patients with adenocarcinoma of the prostate treated with radiation therapy. Int J Radiat Oncol Biol Pliys 1990; 26: 1377-82.
33. Kajanti M, Holsti L, Holsti P, et al. Effect of split course radiotherapy on survival and local control in advanced localised prostatic carcinoma. Int J Radiat Oncol Biol Phys 1992; 26: 211-6.
34. Brierley JD, Keanne TJ, Cummings B, Hao Y. The absence of an adverse effect of prolongation of radiation treatment of primary rectal adenocarcinoma. Clin Oncol 1996; 8: 97-101.
35. Haustermans KMG, Hofland I, Van Poppel, et al. Cell kinetic measurements in prostate cancer. Int J Rad Oncol Biol Phys 1997; 37: 1067-70.
36. Aherne WA, Campeljohn RS, Wright NA. An introduction to cell population kinetics. London: Edward Arnold, 1976.